Supply Chain

The California State Board of Pharmacy is pursuing  disciplinary action against an off-campus UC Los Angeles pharmacy after an investigation last October revealed the facility compounded drugs with "expired and potentially dangerous ingredients," The Los Angeles Times reports.

Here are six drug companies that made headlines in the past week.

Rural hospitals often struggle to keep expensive rare disease drugs stocked and available for patients, since they must pay full price for the medications through the 340B Drug Discount Program, reports NPR.

Here are the five latest drugs or medical devices approved by the Food and Drug Administration in the past week.

The Food and Drug Administration on Thursday approved Amgen and Allergan's biosimilar version of Roche's cancer drug Avastin.

Here are six articles published by Becker's Hospital Review in the last week, featuring Cleveland Clinic's five-step strategy to address rising drug prices and the counterintuitive economic argument favoring price-gouging during a natural disaster, among other topics.

Bayer on Thursday earned accelerated approval from the Food and Drug Administration for its cancer drug Aliqopa.

Israel-based Teva Pharmaceuticals will sell Paragard, its hormone-free intrauterine device, to Pleasanton, Calif.-based Cooper Companies for $1.1 billion, according to Bloomberg.

Pfizer on Sept. 1 earned Food and Drug Administration approval for its acute myeloid leukemia drug Mylotarg.

U.S. hospitals could lower annual supply expenses by about $23 billion in total by improving supply chain processes and adjusting product use, according to a recent report from Navigant.